Publicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria Fundación Jiménez Díaz (19)

2025

  1. Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction

    The New England journal of medicine, Vol. 393, Núm. 19, pp. 1889-1900

  2. Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation

    The New England journal of medicine, Vol. 392, Núm. 14, pp. 1396-1405

  3. Disease activity predicts the development of cardiovascular events in patients with rheumatoid arthritis from the CARMA cohort

    Seminars in Arthritis and Rheumatism, Vol. 75

  4. Evaluating the reliability of cardiovascular risk scales in patients with chronic inflammatory rheumatic diseases

    Seminars in Arthritis and Rheumatism, Vol. 72

  5. Predictive factors of gait recovery after hip fracture: a scoping review

    Age and Ageing, Vol. 54, Núm. 3

  6. The metabolic score for insulin resistance predicts the risk of cardiovascular disease in patients with psoriatic arthritis: results from the 10-year prospective CARMA cohort

    RMD open, Vol. 11, Núm. 1

2024

  1. BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC

    Lung Cancer, Vol. 194

  2. Colchicine in acutely decompensated heart failure: the COLICA trial

    European Heart Journal, Vol. 45, Núm. 45, pp. 4826-4836

  3. Combined use of QRISK3 and SCORE2 increases identification of ankylosing spondylitis patients at high cardiovascular risk: Results from the CARMA Project cohort after 7.5 years of follow-up

    Seminars in Arthritis and Rheumatism, Vol. 66

  4. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

    eClinicalMedicine, Vol. 71

  5. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study

    The Lancet Rheumatology, Vol. 6, Núm. 6, pp. e374-e383

  6. Traditional and Emerging Strategies for Managing Polymyalgia Rheumatica: Insights into New Treatments

    Journal of Clinical Medicine, Vol. 13, Núm. 21

  7. Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period

    RMD open, Vol. 10, Núm. 2

2023

  1. Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry

    International Journal of Antimicrobial Agents, Vol. 62, Núm. 4

  2. Mucosal Immune Defence Gene Polymorphisms as Relevant Players in the Pathogenesis of IgA Vasculitis?

    International Journal of Molecular Sciences, Vol. 24, Núm. 17

  3. Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry

    Journal of hematology & oncology

2022

  1. Clinical management and acute exacerbations in patients with idiopathic pulmonary fibrosis in Spain: results from the OASIS study

    Respiratory Research, Vol. 23, Núm. 1

  2. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: Part 2-care pathways, treatment, and follow-up

    Cardiovascular Research, Vol. 118, Núm. 7, pp. 1618-1666

  3. Effectiveness of CPAP vs. Noninvasive Ventilation Based on Disease Severity in Obesity Hypoventilation Syndrome and Concomitant Severe Obstructive Sleep Apnea

    Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 228-236